Squarepoint
OCS icon

Squarepoint’s Oculis Holding OCS Stock Holding History

Squarepoint’s Portfolio OCS Stock Details OCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$854K Buy
61,605
+47,158
+326% +$1.07M ﹤0.01% 3026
2026
Q1 		$384K Buy
+14,447
New +$382K ﹤0.01% 3518

Other funds holding OCS

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Squarepoint's OCS Position: Q2 2026 in Review

Squarepoint increased its Oculis Holding (OCS) stake by 326% in Q2 2026, buying an estimated $1.07M and bringing the position to 61,605 shares worth $854K. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Squarepoint first reported a position in OCS in Q1 2026 and has held it in 2 quarters since. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • Squarepoint held 61,605 shares of Oculis Holding worth $854K as of Q2 2026.
  • Squarepoint bought 47,158 Oculis Holding shares in Q2 2026, an estimated $1.07M.
  • Oculis Holding made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3026 holding.
  • Squarepoint first reported a position in Oculis Holding in Q1 2026 and has held it in 2 quarters since.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.